AI assistant
ETHZilla Corp — Director's Dealing 2021
Dec 10, 2021
33039_dirs_2021-12-10_41bcb3fd-dc53-4ea4-9e56-4387dc3bcfca.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: 180 Life Sciences Corp. (ATNF)
CIK: 0001690080
Period of Report: 2021-12-08
Reporting Person: Rothbard Jonathan B. (Chief Scientific Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-12-08 | Stock Option (Right to Buy) | $3.95 | A | 300000 | Acquired | 2031-12-08 | Common Stock (300000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 560449 | Direct |
Footnotes
F1: The Stock Options were granted to the Reporting Person pursuant to the Issuer's 2020 Omnibus Incentive Plan in consideration for services to be rendered as Chief Scientific Officer. Exempt from Section 16(b) of the Securities Exchange Act of 1934 under Rule 16b-3.
F2: The options vest at the rate of 1/3rd of such options at the date of grant with the remaining options vesting at the rate of 24 equal monthly installments, beginning on the last day of December 31, 2021, and continuing on the last day of each calendar month thereafter, subject to the Reporting Person's continued service to the Company on such vesting dates.